Advancing Drug Development for the Prevention of Spontaneous Preterm Birth - 01/23/2024

FDA ’s Center for Drug Evaluation and Research and the Duke-Margolis Center for Health Policy will host a jointly sponsored virtual public workshop on Advancing Drug Development for the Prevention of Spontaneous Preterm Birth.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news